Compounds > N-(2-oxo-1-benzopyran-3-yl)acetamide
Page last updated: 2024-09-04

N-(2-oxo-1-benzopyran-3-yl)acetamide and N-(3-oxo-2-benzo[f][1]benzopyranyl)acetamide

N-(2-oxo-1-benzopyran-3-yl)acetamide has been researched along with N-(3-oxo-2-benzo[f][1]benzopyranyl)acetamide in 1 studies

Compound Research Comparison

Studies
(N-(2-oxo-1-benzopyran-3-yl)acetamide)		Trials
(N-(2-oxo-1-benzopyran-3-yl)acetamide)		Recent Studies (post-2010)
(N-(2-oxo-1-benzopyran-3-yl)acetamide)		Studies
(N-(3-oxo-2-benzo[f][1]benzopyranyl)acetamide)		Trials
(N-(3-oxo-2-benzo[f][1]benzopyranyl)acetamide)		Recent Studies (post-2010) (N-(3-oxo-2-benzo[f][1]benzopyranyl)acetamide)
902801

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Harfenist, M; Joyner, CT; Mize, PD; White, HL1

Other Studies

1 other study(ies) available for N-(2-oxo-1-benzopyran-3-yl)acetamide and N-(3-oxo-2-benzo[f][1]benzopyranyl)acetamide

ArticleYear
Selective inhibitors of monoamine oxidase. 2. Arylamide SAR.
    Journal of medicinal chemistry, 1994, Jun-24, Volume: 37, Issue:13

    Topics: Acetamides; Animals; Antidepressive Agents; Binding, Competitive; Brain; Chromatography, Thin Layer; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Rats; Spectrophotometry, Ultraviolet; Structure-Activity Relationship; Substrate Specificity

1994